Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-262532
Filing Date
2025-11-03
Accepted
2025-11-03 16:05:56
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20250930.htm   iXBRL 10-Q 2671616
2 EX-10.1 bdsx-ex10_1.htm EX-10.1 26298
3 EX-31.1 bdsx-ex31_1.htm EX-31.1 16212
4 EX-31.2 bdsx-ex31_2.htm EX-31.2 16230
5 EX-32.1 bdsx-ex32_1.htm EX-32.1 9283
6 EX-32.2 bdsx-ex32_2.htm EX-32.2 9508
  Complete submission text file 0001193125-25-262532.txt   11715878

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20250930.xsd EX-101.SCH 1883517
79 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20250930_htm.xml XML 2039414
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 251444072
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)